Adagene Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 — HC Wainwright & Co. Reiterates Buy → Buy 10/04/2023 87.97% HC Wainwright & Co. → $5 Reiterat

BenzingaJun 28 07:09 ET

H.C. Wainwright Maintains Adagene(ADAG.US) With Buy Rating, Maintains Target Price $5

H.C. Wainwright analyst Arthur He CFA maintains $Adagene(ADAG.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 47.8% and a tot

Moomoo NewsJun 28 06:31 ET · Ratings

Adagene Inc. (NASDAQ:ADAG) Most Popular Amongst Private Equity Firms Who Own 39% of the Shares, Institutions Hold 30%

Yahoo FinanceJun 20 08:04 ET

Express News | Adagene Inc : Jefferies Cuts Target Price to $8 From $26

ReutersJun 7 01:43 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersLiquidia (NASDAQ:LQDA) stock rose 12.7% to $14.5 during Friday's after-market session. The market value of their outstanding shares is at $1.1 billion. Adagene (NASDAQ:ADAG) shares moved upward

BenzingaMay 31 16:32 ET

Adagene to Present at Investor Conferences in June

Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.

GlobeNewswireMay 22 16:45 ET